Skip to main content
OpenTrials
Completed

NCT Number: NCT03958253

Lung Cancer Screening Protocol

The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Cancer Screening

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Southern Illinois Healthcare, Carbondale, Illinois, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
  • Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.

Exclusion criteria

There are not any exclusion criteria for the study

Treatment and study plan

Toolbox for Lung Cancer Screening

Other

-Toolbox of evidence-based elements that a primary care or referral site could implement to address known barriers to screening and referral, as well as required elements for screening. These elements will be designed to be adaptable to the unique needs and screening processes of the participating practices.

  • Patient education materials
  • Primary care practice educational materials
  • Pack-years/eligibility calculator
  • Local referral process guide
  • Smoking cessation materials and support
  • Shared decision-making guide
  • LDCT best practice guidelines

Primary outcomes

  1. Number of initial low-dose CT (LDCT) scan screenings per month per screening center

    Time frame: Completion of study (estimated to be 21 months)

    -Screening will be defined as completed initial screen for lung cancer

Secondary outcomes

  1. Number of primary care providers who refer at least two patients per month for LDCT

    Time frame: Completion of study (estimated to be 21 months)

  2. Percent of patients referred who are screen-eligible

    Time frame: Completion of study (estimated to be 21 months)

    Defined as the number of screen-eligible patients divided by the total of screening procedures performed

  3. Percent of patients referred who complete screening

    Time frame: Completion of study (estimated to be 21 months)

    Defined as the number of patients referred for screening divided by the total number of screening procedures performed.

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • BJC HealthCare, Barnes-Jewish St. Peters Hospital
  • Cox Health Systems
  • Decatur Memorial Hospital
  • Memorial Health System
  • Sarah Bush Lincoln Health System
  • Southern Illinois Healthcare

Registry information

Official study title

I-STEP: Increasing Screening Through Engaging Primary Care Providers

Acronym: I-STEP

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
May 21, 2019
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.